IBEX Technologies (Germany) Performance
IBT Stock | EUR 684.00 10.00 1.48% |
IBEX Technologies has a performance score of 1 on a scale of 0 to 100. The firm retains a Market Volatility (i.e., Beta) of 0.59, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IBEX Technologies' returns are expected to increase less than the market. However, during the bear market, the loss of holding IBEX Technologies is expected to be smaller as well. IBEX Technologies at this time retains a risk of 1.35%. Please check out IBEX Technologies standard deviation, maximum drawdown, kurtosis, as well as the relationship between the total risk alpha and potential upside , to decide if IBEX Technologies will be following its current trending patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in IBEX Technologies are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, IBEX Technologies is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow | 4.4 M | |
Total Cashflows From Investing Activities | -144.8 K |
IBEX |
IBEX Technologies Relative Risk vs. Return Landscape
If you would invest 68,000 in IBEX Technologies on September 21, 2024 and sell it today you would earn a total of 400.00 from holding IBEX Technologies or generate 0.59% return on investment over 90 days. IBEX Technologies is currently producing 0.0181% returns and takes up 1.348% volatility of returns over 90 trading days. Put another way, 12% of traded stocks are less volatile than IBEX, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
IBEX Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IBEX Technologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IBEX Technologies, and traders can use it to determine the average amount a IBEX Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0134
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | IBT |
Estimated Market Risk
1.35 actual daily | 12 88% of assets are more volatile |
Expected Return
0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average IBEX Technologies is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IBEX Technologies by adding it to a well-diversified portfolio.
IBEX Technologies Fundamentals Growth
IBEX Stock prices reflect investors' perceptions of the future prospects and financial health of IBEX Technologies, and IBEX Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IBEX Stock performance.
Return On Equity | 0.18 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.21 % | |||
Operating Margin | 0.27 % | |||
Current Valuation | 4.1 M | |||
Shares Outstanding | 24.78 M | |||
Price To Earning | 6.10 X | |||
Price To Book | 1.15 X | |||
Price To Sales | 1.13 X | |||
Revenue | 7.89 M | |||
EBITDA | 2.83 M | |||
Cash And Equivalents | 4.21 M | |||
Cash Per Share | 0.17 X | |||
Total Debt | 666.13 K | |||
Debt To Equity | 0.08 % | |||
Book Value Per Share | 0.42 X | |||
Cash Flow From Operations | 3.58 M | |||
Earnings Per Share | 0.05 X | |||
Total Asset | 12.97 M | |||
About IBEX Technologies Performance
By analyzing IBEX Technologies' fundamental ratios, stakeholders can gain valuable insights into IBEX Technologies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IBEX Technologies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IBEX Technologies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally. IBEX Technologies Inc. was founded in 1986 and is based in Montreal, Canada. IBEX TECHS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.Things to note about IBEX Technologies performance evaluation
Checking the ongoing alerts about IBEX Technologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IBEX Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.About 27.0% of the company shares are held by company insiders |
- Analyzing IBEX Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IBEX Technologies' stock is overvalued or undervalued compared to its peers.
- Examining IBEX Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IBEX Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of IBEX Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IBEX Technologies' stock. These opinions can provide insight into IBEX Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for IBEX Stock analysis
When running IBEX Technologies' price analysis, check to measure IBEX Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IBEX Technologies is operating at the current time. Most of IBEX Technologies' value examination focuses on studying past and present price action to predict the probability of IBEX Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IBEX Technologies' price. Additionally, you may evaluate how the addition of IBEX Technologies to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Fundamental Analysis View fundamental data based on most recent published financial statements |